| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 90.7872 | 74 |
| GSM780708 | Untreated after 4 days (C2_1) | 79.1627 | 71 |
| GSM780709 | Untreated after 4 days (C3_1) | 77.1389 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 76.6252 | 71 |
| GSM780720 | Untreated after 4 days (C2_2) | 86.1357 | 73 |
| GSM780721 | Untreated after 4 days (C3_2) | 87.9427 | 73 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 80.7342 | 72 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 76.3781 | 71 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 90.5652 | 74 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 80.1436 | 72 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 90.6698 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 94.1155 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 82.1484 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 73.5625 | 70 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 94.0507 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 92.831 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 89.6048 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 93.0176 | 74 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 94.2067 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 93.791 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 73.931 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 102.44 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 85.2194 | 73 |